Standard BioTools Inc. (LAB) News

Standard BioTools Inc. (LAB): $1.99

0.01 (+0.51%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Filter LAB News Items

LAB News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

LAB News Highlights

  • For LAB, its 30 day story count is now at 4.
  • Over the past 21 days, the trend for LAB's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
  • The most mentioned tickers in articles about LAB are CELL.

Latest LAB News From Around the Web

Below are the latest news stories about STANDARD BIOTOOLS INC that investors may wish to consider to help them evaluate LAB as an investment opportunity.

Standard BioTools Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

SOUTH SAN FRANCISCO, Calif., March 22, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB) today announced that the Compensation Committee of its Board of Directors, which is composed entirely of independent directors, granted an equity award effective as of March 20, 2023, under the Standard BioTools Inc. 2022 Inducement Equity Incentive Plan (Plan). The equity award consisted of an award of nonstatutory stock options to purchase 647,112 shares of common stock and an award of 112,293 r

Yahoo | March 22, 2023

Standard BioTools Announces Appointment of Fenel Eloi to Board of Directors

Experienced Life Science Operating Leader Joins Board as Company Enters New PhaseSOUTH SAN FRANCISCO, Calif., March 15, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health – today announced the appointment of Fenel Eloi to its Board of Directors (“Board”). Eloi will also serve on the Board’s Audit Committee. Eloi was most recently the Chief Financial Officer and then Chief Operating Officer of Cell

Yahoo | March 15, 2023

Standard BioTools to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum

SOUTH SAN FRANCISCO, Calif., March 14, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health – today announced that President and Chief Executive Officer Michael Egholm, PhD, will participate in a fireside chat at the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum on Tuesday, March 21, 2023, at 3:00 p.m. ET. The presentation will be webcast live and available on the Investor Relations

Yahoo | March 14, 2023

Standard BioTools to Present at 43rd Annual Cowen Health Care Conference

SOUTH SAN FRANCISCO, Calif., March 01, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health – today announced that President and Chief Executive Officer Michael Egholm, PhD, will present at the Cowen Health Care Conference on Wednesday, March 8, 2023, at 12:50 p.m. ET. The presentation will be webcast live and available on the Investor Relations page of the company’s website at Events & Presentations

Yahoo | March 1, 2023

Standard BioTools Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SOUTH SAN FRANCISCO, Calif., Feb. 21, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB) today announced that the Compensation Committee of its Board of Directors, which is composed entirely of independent directors, granted equity awards effective as of February 20, 2023, under the Standard BioTools Inc. 2022 Inducement Equity Incentive Plan (Plan), as a material inducement to four individuals entering into employment with Standard BioTools™. The equity awards were approved in accorda

Yahoo | February 21, 2023

Standard BioTools Inc. (NASDAQ:LAB) Q4 2022 Earnings Call Transcript

Standard BioTools Inc. (NASDAQ:LAB) Q4 2022 Earnings Call Transcript February 14, 2023 Operator: Hello, and welcome to the Standard BioTools Inc. Fourth Quarter and Full Year 2022 Financial Results Conference Call. As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Peter DeNardo, Investor Relations. Thank you. Mr. […]

Yahoo | February 17, 2023

How a Peninsula biotech tools company looks to corral 'one-trick ponies'

The 24-year-old company, founded as Fluidigm, got a $250 million influx from two hedge funds and brought in new management.

Yahoo | February 15, 2023

Standard BioTools Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Business Outlook

Fourth quarter 2022 GAAP revenues of $27.0 million; Core product and service revenues of $26.8 million, representing 8.3% sequential growth; Full year GAAP revenues of $97.9 million and core product and service revenues of $94.5 million Improved operating discipline and restructuring initiatives contributed to a 16% sequential decrease in operating expenses in the fourth quarter; Product and services margin improved sequentially by 620 basis points on a GAAP basis, 520 basis points on a non-GAAP

Yahoo | February 14, 2023

The past five years for Standard BioTools (NASDAQ:LAB) investors has not been profitable

Standard BioTools Inc. ( NASDAQ:LAB ) shareholders will doubtless be very grateful to see the share price up 82% in the...

Yahoo | February 3, 2023

Standard BioTools Announces Conference Call and Webcast for Fourth Quarter and Full Year 2022 Financial Results

SOUTH SAN FRANCISCO, Calif., Jan. 31, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health – today announced that it will report fourth quarter and full year 2022 financial results on Tuesday, February 14, 2023, after the close of the market. The Company’s management will host a conference call and webcast at 2:00 p.m. PT, 5:00 p.m. ET, on February 14, 2023, to discuss fourth quarter and full year 20

Yahoo | January 31, 2023


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.83 seconds.